Compare ATLO & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATLO | ORGO |
|---|---|---|
| Founded | 1903 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.2M | 239.3M |
| IPO Year | 2001 | 2016 |
| Metric | ATLO | ORGO |
|---|---|---|
| Price | $31.68 | $1.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 24.0K | ★ 884.1K |
| Earning Date | 04-24-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.43% | N/A |
| EPS Growth | 8.03 | ★ 1600.00 |
| EPS | ★ 0.38 | N/A |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.27 |
| P/E Ratio | $83.50 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $19.56 | $1.54 |
| 52 Week High | $32.30 | $7.08 |
| Indicator | ATLO | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 56.36 | 34.40 |
| Support Level | $28.88 | $1.54 |
| Resistance Level | $32.16 | $2.64 |
| Average True Range (ATR) | 0.74 | 0.12 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 60.19 | 29.78 |
Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.